Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
ALDH4A1
Introduction
Aldehyde dehydrogenase 4 family, member A1, also known as ALDH4A1, is a human gene.[1]
This protein belongs to the aldehyde dehydrogenase family of proteins. This enzyme is a mitochondrial matrix NAD-dependent dehydrogenase which catalyzes the second step of the proline degradation pathway, converting pyrroline-5-carboxylate to glutamate. Deficiency of this enzyme is associated with type II hyperprolinemia, an autosomal recessive disorder characterized by accumulation of delta-1-pyrroline-5-carboxylate (P5C) and proline. Two transcript variants encoding the same protein have been identified for this gene.[1]
Further reading
Further reading
- Valle D, Goodman SI, Harris SC, Phang JM (1980). “Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline”. J. Clin. Invest. 64 (5): 1365–70. PMID 500817.
- Hochstrasser DF, Frutiger S, Paquet N; et al. (1993). “Human liver protein map: a reference database established by microsequencing and gel comparison”. Electrophoresis. 13 (12): 992–1001. PMID 1286669.
- Goodman SI, Mace JW, Miles BS; et al. (1974). “Defective hydroxyproline metabolism in type II hyperprolinemia”. Biochemical medicine. 10 (4): 329–36. PMID 4851275.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. PMID 8125298.
- Hu CA, Lin WW, Valle D (1996). “Cloning, characterization, and expression of cDNAs encoding human delta 1-pyrroline-5-carboxylate dehydrogenase”. J. Biol. Chem. 271 (16): 9795–800. PMID 8621661.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. PMID 9373149.
- Geraghty MT, Vaughn D, Nicholson AJ; et al. (1998). “Mutations in the Delta1-pyrroline 5-carboxylate dehydrogenase gene cause type II hyperprolinemia”. Hum. Mol. Genet. 7 (9): 1411–5. PMID 9700195.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Twizere JC, Kruys V, Lefèbvre L; et al. (2004). “Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression”. J. Natl. Cancer Inst. 95 (24): 1846–59. PMID 14679154.
- Yoon KA, Nakamura Y, Arakawa H (2004). “Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses”. J. Hum. Genet. 49 (3): 134–40. doi:10.1007/s10038-003-0122-3. PMID 14986171.
- Gerhard DS, Wagner L, Feingold EA; et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
- Gregory SG, Barlow KF, McLay KE; et al. (2006). “The DNA sequence and biological annotation of human chromosome 1”. Nature. 441 (7091): 315–21. doi:10.1038/nature04727. PMID 16710414.